Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers’ Comp Data: Healthcare Industry Sector is the Source of the Majority of COVID-19 Claims
Data analysis by Aarthi Thiruvengadam Over the first few months of the COVID-19 pandemic, the workers’ compensation industry has gone thro
Therapeutic Alternatives—A Closer Look
Brand name medications are often scrutinized by the workers’ compensation industry for their high cost.
Brand and Generic Medication Trends
Part Two: Evaluating In-Network and Out-of-Network Trends In this final post related to our in-network and out-of-network analysis we
Pain Management and Opioid Recovery
Taking a multi-disciplinary approach to ongoing pain management and opioid recovery
Industrial Commission of Arizona Releases Revised Draft Fee Schedule Proposal
Following up on comments received at their June 25, 2020, hearing, the Industrial Commission of Arizona released a revised version of their draft f
Getting Into Insurance? The Insurance Industry Outlook is Brighter than Ever
Over the last decade, the insurance industry has undergone dramatic changes that have catapulted it to the forefront of the American consciousness,